Literature DB >> 3951822

Treatment of superior limbic keratoconjunctivitis by thermocauterization of the superior bulbar conjunctiva.

I J Udell, K R Kenyon, M Sawa, C H Dohlman.   

Abstract

Superior limbic keratoconjunctivitis (SLK) is a chronic and recurrent inflammatory disease of the superior tarsal, bulbar and limbal conjunctiva that often responds to topical treatment with silver nitrate. As an alternative treatment in 11 patients (13 eyes), we applied thermal cautery to the inflamed superior bulbar conjunctiva following subconjunctival injection of 2% xylocaine. The overall positive response rate to thermocautery was 73% (8 patients). Of the positive responders, 63% (5 patients) had been considered silver nitrate treatment failures. Keratitis sicca was additionally noted in 55% of the patients studied. Impression cytology of involved superior bulbar conjunctiva was nearly devoid of goblet cells during the acute stage of the disorder. Following successful cauterization, goblet cells returned. Thus, thermocauterization of the superior bulbar conjunctiva appears to be a safe and effective mode of therapy for SLK.

Entities:  

Mesh:

Year:  1986        PMID: 3951822     DOI: 10.1016/s0161-6420(86)33766-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

1.  Treatment of superior limbic keratoconjunctivitis with a unilateral bandage contact lens.

Authors:  S Watson; A B Tullo; F Carley
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  Dry eye and Meige's syndrome.

Authors:  K Tsubota; T Fujihara; M Kaido; A Mori; M Mimura; M Kato
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

3.  Superior Limbic Keratoconjunctivitis-like Inflammation in Patients with Chronic Graft-Versus-Host Disease.

Authors:  Kavitha R Sivaraman; Renu V Jivrajka; Ketki Soin; Charles S Bouchard; Asadolah Movahedan; Ellen Shorter; Sandeep Jain; Deborah S Jacobs; Ali R Djalilian
Journal:  Ocul Surf       Date:  2016-05-12       Impact factor: 5.033

4.  Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.

Authors:  Alejandro Rodriguez-Garcia; Yolanda Macias-Rodriguez; Jose M Gonzalez-Gonzalez
Journal:  Int Ophthalmol       Date:  2017-06-10       Impact factor: 2.031

5.  The application of in vivo laser scanning confocal microscopy as a tool of conjunctival in vivo cytology in the diagnosis of dry eye ocular surface disease.

Authors:  Takashi Kojima; Yukihiro Matsumoto; Murat Dogru; Kazuo Tsubota
Journal:  Mol Vis       Date:  2010-11-19       Impact factor: 2.367

6.  Liquid nitrogen cryotherapy for surface eye disease (an AOS thesis).

Authors:  Frederick Web Fraunfelder
Journal:  Trans Am Ophthalmol Soc       Date:  2008

7.  Regional Comparison of Goblet Cell Number and Area in Exposed and Covered Dry Eyes and Their Correlation with Tear MUC5AC.

Authors:  Karima S Khimani; Jonathan A Go; Rodrigo Guimaraes De Souza; Travis Mitchell; Zhiyuan Yu; Cintia S de Paiva; Meghan Saumur; Stephen C Pflugfelder
Journal:  Sci Rep       Date:  2020-02-19       Impact factor: 4.379

8.  Accelerated corneal collagen cross-linking in clinical management of infectious keratitis.

Authors:  Miao Li; Tao Yu; Xin Gao; Xin-Yi Wu
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.